Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,607,714
-$9,544,398 QoQ
Shares Held
8,200
-65.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#131
of 505 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Derivatives in ARGX
reported options exposure · as of Jun 30, 2026CallValue
$18,926,508
CallShares
20,400
PutValue
$3,061,641
PutShares
3,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. ARGX ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
134,214 | $40,402,439 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
223,995 | $21,835,032 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,306 | $13,908,683 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
347,106 | $10,850,533 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
5,112,098 | $8,521,240 | |
| 6 | ARGX |
Argenx SE
This page
|
8,200 | $7,607,714 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
150,200 | $7,065,408 | |
| 8 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 |
All Filings in ARGX
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,926,508 | 20,400 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $3,061,641 | 3,300 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $7,607,714 | 8,200 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,436,600 | 18,400 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $17,152,112 | 23,488 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $62,230,300 | 74,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $3,200,655 | 3,806 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $94,038,900 | 127,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $6,490,528 | 8,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,465,376 | 20,800 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $33,018,078 | 59,900 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $7,771,187 | 13,130 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $15,447,676 | 26,100 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $11,568,150 | 18,810 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $13,407,000 | 21,800 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $9,645,771 | 17,794 | Shares | Sole | 2024-11-07 | |
| 2024-09-30 | $23,309,440 | 43,000 | Call | Sole | 2024-11-07 | |
| 2024-09-30 | $11,329,472 | 20,900 | Put | Sole | 2024-11-07 | |
| 2024-06-30 | $3,698,344 | 8,600 | Call | Other | 2024-08-14 | |
| 2024-06-30 | $1,075,100 | 2,500 | Shares | Other | 2024-08-14 | |
| 2024-06-30 | $473,044 | 1,100 | Put | Other | 2024-08-14 | |
| 2023-12-31 | $2,358,666 | 6,200 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $418,473 | 1,100 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $540,793 | 1,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,936,273 | 10,100 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $38,973 | 100 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $389,730 | 1,000 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $11,364,900 | 30,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,591,500 | 30,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,788,800 | 10,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,306,200 | 20,000 | Shares | Sole | 2022-05-16 | |
| 2020-03-31 | $1,333,897 | 10,126 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||